Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
Recruitment status was: Active, not recruiting
Greater trochanteric pain syndrome (GTPS) is a common cause of musculoskeletal pain.
The primary aim of this study is to describe the soft tissue and bony structural ultrasound (US) findings identified in the lateral hip and iliotibial band (ITB) in patients presenting with greater trochanteric pain syndrome (GTPS) in an outpatient rheumatology clinic.
Greater Trochanteric Pain Syndrome
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome (GTPS)|
- Descriptive diagnostic ultrasound findings of the bony and soft tissue structures of the lateral hip and iliotibial band [ Time Frame: Baseline ]Presence of tendinopathy, tendon tears, bursitis, enthesophytes, calcifications
- Pain with rest measured by a numeric rating scale [ Time Frame: Baseline and 2 weeks ]
- Pain with activity as measured by a numeric rating scale [ Time Frame: Baseline and 2 weeks ]
- Demographics- composite [ Time Frame: Baseline ]age, gender, race/ethnicity, education, occupation, comorbidities, overall health status.
- Pressure point threshold as measured by an algometer [ Time Frame: Baseline ]
- Clinical data: Predictors of treatment response- composite [ Time Frame: Baseline ]
- Duration of pain
- Body Mass Index
- Physical exam findings
- Treatments tried in the past
- Presence of back pain
|Study Start Date:||June 2012|
|Estimated Study Completion Date:||August 2015|
|Estimated Primary Completion Date:||August 2015 (Final data collection date for primary outcome measure)|
GTPS, widely known as trochanteric bursitis, encompasses a spectrum of disorders (gluteal tendinopathy, tears, bursitis, and ITB syndrome) that are difficult to distinguish by clinical exam alone. Better understanding of US imaging characteristics in relation to clinical symptoms may be helpful in identifying those patients who would most benefit from corticosteroid injections and other non-operative treatment options.
Point-of-care musculoskeletal US use has been shown to reduce repeated hospital appointments, improve accuracy of diagnosis, and provide expedited treatment, thus improving quality of care in an outpatient musculoskeletal clinic. US assessment is not routinely included in the management of GTPS patients and ideal imaging modalities are not established.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01642043
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Minna J. Kohler, M.D.||Massachusetts General Hospital|